MYNZ
Mainz Biomed BV
NASDAQ: MYNZ · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.41
-3.73% today
Updated 2026-05-01
Market cap
$7.90M
P/E ratio
—
P/S ratio
16.01x
EPS (TTM)
$-5.28
Dividend yield
—
52W range
$1 – $5
Volume
0.8M
Mainz Biomed BV (MYNZ) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.41
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$0.52
Financial forecast
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.